These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12296411)

  • 1. Comparative study of the efficacy of topical corticosteroid: five locally made and one brand name creams.
    Puavilai S; Krisadaphong P; Leenutaphong V; Asawanonda P; Akaraphan R; Ploysangham T; Ruangkarnchanasetr S; Noppakun N; Charuwichitratana S; Kulthanan K; Huiprasert P; Tresukosol P; Ophaswongse S
    J Med Assoc Thai; 2002 Jul; 85(7):789-99. PubMed ID: 12296411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
    Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis.
    Jarratt M; Breneman D; Gottlieb AB; Poulin Y; Liu Y; Foley V
    J Drugs Dermatol; 2004; 3(4):367-73. PubMed ID: 15303780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiinflammatory effect of a topical corticosteroid: known brand versus generic drug].
    Castanedo-Cázares JP; Quistián-Galván J; Torres-Alvarez B; Torres-Ruvalcaba A; Moncada B
    Gac Med Mex; 2001; 137(4):311-4. PubMed ID: 11519354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis.
    Beutner K; Chakrabarty A; Lemke S; Yu K
    J Drugs Dermatol; 2006 Apr; 5(4):357-60. PubMed ID: 16673804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasis.
    Menter A
    Cutis; 2012 Feb; 89(2):89-94. PubMed ID: 22474733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.
    Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ
    J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.
    Decroix J; Pres H; Tsankov N; Poncet M; Arsonnaud S
    Cutis; 2004 Sep; 74(3):201-6. PubMed ID: 15499763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.
    Lebwohl M; Sherer D; Washenik K; Krueger GG; Menter A; Koo J; Feldman SR
    Int J Dermatol; 2002 May; 41(5):269-74. PubMed ID: 12100701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
    Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
    Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison.
    Lee CS; Koo J
    J Drugs Dermatol; 2009 Aug; 8(8):751-5. PubMed ID: 19663113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The same glucocorticoid in brand-name products. Does increasing the concentration result in greater topical biologic activity?
    Stoughton RB; Wullich K
    Arch Dermatol; 1989 Nov; 125(11):1509-11. PubMed ID: 2817915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial.
    Campisi G; Giandalia G; De Caro V; Di Liberto C; Aricò P; Giannola LI
    Br J Dermatol; 2004 May; 150(5):984-90. PubMed ID: 15149513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clobetasol propionate for psoriasis: are ointments really more potent?
    Warino L; Balkrishnan R; Feldman SR
    J Drugs Dermatol; 2006 Jun; 5(6):527-32. PubMed ID: 16774104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clobetasol--a potent new topical corticosteroid.
    Med Lett Drugs Ther; 1986 Jun; 28(715):57-9. PubMed ID: 3520267
    [No Abstract]   [Full Text] [Related]  

  • 17. Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial.
    Conrotto D; Carbone M; Carrozzo M; Arduino P; Broccoletti R; Pentenero M; Gandolfo S
    Br J Dermatol; 2006 Jan; 154(1):139-45. PubMed ID: 16403107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment.
    Sánchez Regaña M; Márquez Balbás G; Umbert Millet P
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):963-9. PubMed ID: 18410337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D and scalp psoriasis.
    Koo J
    Cutis; 2002 Nov; 70(5 Suppl):21-4. PubMed ID: 12467336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis.
    Lowe N; Feldman SR; Sherer D; Weiss J; Shavin JS; Lin YL; Foley V; Soto P
    J Dermatolog Treat; 2005 Aug; 16(3):158-64. PubMed ID: 16096182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.